Cord colitis syndrome
Cord colitis syndrome is a medical condition that occurs in patients who have undergone umbilical cord blood transplantation. This syndrome is characterized by gastrointestinal symptoms, including diarrhea, abdominal pain, and fever. It is a relatively newly recognized condition, first described in 2011.
Etiology
The exact cause of cord colitis syndrome is not fully understood. However, it is believed to be related to the immune system's response to the transplanted umbilical cord blood. The condition is thought to be a form of graft-versus-host disease (GVHD), where the donor's immune cells attack the recipient's body tissues.
Symptoms
Patients with cord colitis syndrome typically present with:
Diagnosis
The diagnosis of cord colitis syndrome is primarily clinical, based on the patient's history of umbilical cord blood transplantation and the presence of characteristic symptoms. Endoscopy and biopsy of the gastrointestinal tract may be performed to rule out other causes of the symptoms and to confirm the diagnosis.
Treatment
Treatment for cord colitis syndrome often involves the use of antibiotics and immunosuppressive drugs. The specific choice of medication may vary depending on the severity of the symptoms and the patient's overall health. Commonly used antibiotics include metronidazole and ciprofloxacin.
Prognosis
The prognosis for patients with cord colitis syndrome varies. Some patients respond well to treatment and experience a complete resolution of symptoms, while others may have a more chronic course. Early diagnosis and appropriate treatment are crucial for improving outcomes.
Related Pages
- Umbilical cord blood transplantation
- Graft-versus-host disease
- Immune system
- Gastrointestinal tract
- Endoscopy
- Antibiotics
Categories
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
